|
⚲
|
| Keyboard |
| Parker Albert P
✚
|
|
|---|---|
| CIK # | 0001750079 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001750079] | |
| 4 | [0001750079] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Parker Albert P | |
| Zynerba Pharmaceuticals Inc | |
| Oncocyte Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Zynerba Pharmaceuticals Inc ZYNE
Common Stock
|
2023-10-10 | Grant | 85,000 | ||
|
Zynerba Pharmaceuticals Inc ZYNE
Stock Option (Right to Buy) · derivative
|
2023-10-10 | Disposed to issuer | 200,000 | ||
|
Zynerba Pharmaceuticals Inc ZYNE
Common Stock
|
2023-10-10 | Tender | 33,685 | ||
|
Zynerba Pharmaceuticals Inc ZYNE
Common Stock
|
2023-10-10 | Tender | 278,333 | ||
|
Zynerba Pharmaceuticals Inc ZYNE
Common Stock
|
2023-02-15 | Sell | 3,173 | $0.54 | 1,713 |
|
Zynerba Pharmaceuticals Inc ZYNE
Common Stock
|
2023-02-08 | Tax withheld | 5,463 | $0.60 | 3,278 |
|
Zynerba Pharmaceuticals Inc ZYNE
Common Stock
|
2023-02-07 | Grant | 18,864 | ||
|
Zynerba Pharmaceuticals Inc ZYNE
Common Stock
|
2023-02-01 | Tax withheld | 5,841 | $0.60 | 3,505 |
|
Zynerba Pharmaceuticals Inc ZYNE
Common Stock
|
2023-01-31 | Grant | 17,631 | ||
|
Zynerba Pharmaceuticals Inc ZYNE
Common Stock
|
2023-01-24 | Grant | 170,000 | $0.00 | |
|
Zynerba Pharmaceuticals Inc ZYNE
Stock Option (right to buy) · derivative
|
2022-02-14 | Grant | 200,000 | $0.00 | |
|
Zynerba Pharmaceuticals Inc ZYNE
Common Stock
|
2022-02-14 | Grant | 35,000 | $0.00 | |
|
Oncocyte Corp OCX
Common Stock
|
2020-12-11 | Grant | 5,586 | ||
|
Oncocyte Corp OCX
Common Stock, no par value
|
2020-08-03 | Buy | 5,000 | $1.33 | 6,650 |
|
Oncocyte Corp OCX
Option to purchase common stock · derivative
|
2020-02-10 | Grant | 204,000 | $0.00 | |
|
Oncocyte Corp OCX
Option to Purchase Common Stock · derivative
|
2019-03-14 | Grant | 200,000 | $0.00 |